Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10
Published April 19, 2023 · Recall initiated: March 14, 2023
Summary
FDA records drug Class II recall D-0530-2023, published April 19, 2023 and initiated March 14, 2023. Recalling firm: Hetero USA Inc; Status: Ongoing; Reported quantity: 2,352 bottles; Lot: Lot #: PAN22542, Exp. Date: 9/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Discoloration
What to do
Letter
Get an email if PANTOPRAZOLE SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PANTOPRAZOLE SODIUM
- Manufacturer
- Hetero USA Inc
- Distributor
- Nationwide within the United States
- UPC
- 0331722713900
- Lot
- Lot #: PAN22542, Exp. Date: 9/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag inSeptember 9, 2026
- FDAPantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: CamberApril 29, 2026
- FDAPantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10September 20, 2023
- FDANorepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDCApril 19, 2023
- FDABevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each SyringeApril 19, 2023
- FDAPantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce onlyNovember 30, 2022
Questions about this recall
Was Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10 recalled?
Yes. FDA published recall D-0530-2023 on April 19, 2023. Reported hazard: CGMP Deviations: Discoloration
What should I do if I have this product?
Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PANTOPRAZOLE SODIUM. UPC: 0331722713900.